Biogen (NASDAQ:BIIB) Target Lowered by Cantor Fitzgerald to $259.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Cantor Fitzgerald on 10/28/2021. In a note to investors, the firm issued a new target price of $259.00. The analysts previously had $316.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Cantor Fitzgerald to $259.00

Biogen (NASDAQ:BIIB) Target Lowered by Morgan Stanley to $440.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Morgan Stanley on 10/21/2021. In a note to investors, the firm issued a new target price of $440.00. The analysts previously had $447.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Morgan Stanley to $440.00

Biogen (NASDAQ:BIIB) Target Lowered by Oppenheimer Holdings Inc. to $390.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Oppenheimer Holdings Inc. on 10/21/2021. In a note to investors, the firm issued a new target price of $390.00. The analysts previously had $450.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Oppenheimer Holdings Inc. to $390.00

Biogen (NASDAQ:BIIB) Target Lowered by Royal Bank of Canada to $295.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Royal Bank of Canada on 10/21/2021. In a note to investors, the firm issued a new target price of $295.00. The analysts previously had $325.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Royal Bank of Canada to $295.00

Biogen (NASDAQ:BIIB) Target Lowered by Needham & Company LLC to $398.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Needham & Company LLC on 10/19/2021. In a note to investors, the firm issued a new target price of $398.00. The analysts previously had $400.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Needham & Company LLC to $398.00

Biogen (NASDAQ:BIIB) Target Lowered by Stifel Nicolaus to $344.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Stifel Nicolaus on 10/15/2021. In a note to investors, the firm issued a new target price of $344.00. The analysts previously had $430.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Stifel Nicolaus to $344.00

Biogen (NASDAQ:BIIB) Target Lowered by Stifel Nicolaus to $344.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Stifel Nicolaus on 10/15/2021. In a note to investors, the firm issued a new target price of $344.00. The analysts previously had $430.00 target price.

View More Biogen (NASDAQ:BIIB) Target Lowered by Stifel Nicolaus to $344.00